Amneal Pharmaceuticals, Inc. (AMRX)
Nasdaq: AMRX · Pharmaceutical Preparations · filing with the SEC since 2017
Grade5.3
◀ Past 4.9● Present 6.3▶ Future 4.3
Filings
306 filings since 2017 beside 389 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Mar 25, 2026.
Filings a yearinsider forms included
9173515685649376
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Jul 21, 2025.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Dec 15, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 3, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Oct 23, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Aug 10, 2026
Aug 10, 2026
8-K items 1.01, 2.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jul 30, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 22, 2026
8-K items 1.01, 2.02, 3.02, 7.01, 9.01
Major agreement signed; Results released; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Feb 27, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Feb 3, 2026
8-K items 1.01, 2.03
Major agreement signed; New debt or obligation taken on · Current report
Feb 2, 2026
Jan 13, 2026
8-K items 2.02, 7.01
Results released; Investor disclosure (Regulation FD) · Current report
Oct 30, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
40 of 306 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.